In the latest report from the Evernorth Research Institute, learn how biosimilars expand patient choice, lower specialty medication costs, and deliver meaningful savings to employers and patients.
Uncovering news and insights
We’re constantly working to unlock new ideas that can drive progress. Here you’ll find research, data analysis, and expert perspectives to help you create better outcomes for your people.
Close search filters
Changing filters will change the listed Success Criteria and Techniques
Search results (282)
Article
How Evernorth helps providers and health systems deliver comprehensive care to patients
July 11, 2024
Today, health systems are facing a variety of challenges, among them, staffing shortages, rapidly increasing patient demand, and rising costs.
Article
Strong independent pharmacies are the backbone of equitable health care across the United States
July 05, 2024
Article
Leveraging biosimilars to drive savings and support patient access
July 01, 2024
By the end of 2024, 3 FDA-approved biosimilars to Stelara for patients living with inflammatory conditions will be closer to launch, enabling lower total drug spend.
Article
Podcast: Employers have the power to change the trajectory of the youth mental health crisis
June 20, 2024
In this episode of "Health Unscripted," Eva Borden, president of Evernorth Behavioral Health, emphasizes the need for U.S. employers to leverage their influence through health insurance, workplace culture, and community engagement to change the crisis trajectory.
Article
Rethinking advanced maternal age pregnancy
June 13, 2024
Plan sponsors can support expecting mothers aged 35+ with prenatal care, despite long-standing assumptions their pregnancies are high risk.
Article
Connecting GLP-1 weight loss and mental health support for plan sponsors
June 12, 2024
Learn about the behavioral health considerations that employers should be mindful of when it comes to GLP-1 users.
